Skip to main content
SpringerLink
Log in

Hypertension in the elderly: Age- and disease-related complications and therapeutic implications

  • Review
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Effective treatment of hypertension in the elderly requires an understanding of both the progressive course of the disease and the impact of aging on the cardiovascular system, including physiological, genetic, lifestyle, and environmental factors. Review of the literature that has attempted to define the impact of an “aging process” on cardiovascular structure and function reveals a diversity of findings and interpretations. However, in general, normotensive elderly subjects exhibit the heart and vascular characteristics of “muted” hypertension, including many features of younger hypertensive patients: cardiac hypertrophy, diminution in resting left ventricular early diastolic filling rate, increased arterial stiffness and aortic impedance, diminution in the baroreceptor reflex, a diminished response to catecholamines and diminished renal blood flow, and an increase in peripheral vascular resistance (PVR). Treatment of elderly hypertensives is more challenging because of the greater likelihood of the presence of concomitant diseases, most importantly, coronary and peripheral atherosclerosis, renal dysfunction, and diabetes mellitus. Isolated systolic hypertension (ISH), the most common form of hypertension in the elderly, has also been clearly shown to be an important predictor of cardiovascular morbidity and mortality, including coronary artery disease, congestive heart failure, and stroke. Treatment of ISH has been shown to lower systolic pressure safely and effectively in the elderly. By reducing PVR, and possibly the arterial stiffness, and thus the early reflected pulse waves, vasodilators, including calcium antagonists, may lower these three components of arterial impedance, and hence lower the arterial load on the heart. The cardiac hypertrophy and reduced left ventricular filling rate associated with hypertension in older individuals can also be ameliorated, to some extent, by calcium channel blockers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the Pooling Project.J Chronic Dis 1978;31:201–306.

    Google Scholar 

  2. Kannel WB, Vokonas PS. Primary risk factors for coronary heart disease in the elderly: The Framingham Study. In: Wenger NK, Furberg CD, Pitt E, eds.Coronary Heart Disease in the Elderly. New York: Elsevier, 1986:60–92.

    Google Scholar 

  3. Lakatta EG, Cardiovascular system. In: Kent B, Butler R, eds.Aging: Human Aging Research: Concepts and Techniques, Vol. 34: New York: Raven Press, 1988:199.

    Google Scholar 

  4. Messerli FH, Frohlich ED, Suarez DH, et al. Borderline hypertension: Relationship between age, hypertension, and circulating catecholamines.Circulation 1981;64:760.

    Google Scholar 

  5. Amery A, Wasir H, Bulpitt C, et al. Aging and the cardiovascular system.Acta Cardiol 1981;33:443.

    Google Scholar 

  6. Terasawa F, Kuramota K, Ying LH, et al. The study of the hemodynamics in old hypertensive subjects.Acta Gerontol Jpn 1972;56:47.

    Google Scholar 

  7. Tsuchiya M, Kawasaki S, Masuya K, et al. Cardiovascular function in hypertension: The effect of aging on the hemodynamics.Jpn J Geriatr 1973;10:135.

    Google Scholar 

  8. Ting CT, Brin KP, Lin SJ, et al. Arterial hemodynamics in human hypertension.J Clin Invest 1986;78:1462.

    Google Scholar 

  9. Blaustein MP. How salt causes hypertension: The natriuretic hormone— Na/Ca exchange—hypertension hypothesis.Klin Wochenschr 1985;63(Suppl III):82.

    Google Scholar 

  10. Gardin JM, Henry WL, Savage DD, et al. Echocardiographic assessment in normal subjects: Evaluation of an adult population without clinically apparent heart disease.J Clin Ultrasound 1979;7:439.

    Google Scholar 

  11. Gerstenblith G, Frederiksen J, Yin FCP, et al. Echocardiographic assessment of a normal adult population.Circulation 1977;56:273.

    Google Scholar 

  12. Sjogren AL, Left ventricular wall thickness determined by ultrasound in 100 subjects without heart disease.Chest 1971;60:341.

    Google Scholar 

  13. Lakatta EG. Alterations in the cardiovascular system that occur in advanced age.Fed Proc 1979;38:163.

    Google Scholar 

  14. Devereux RB, Savage DD, Drayer JIM, et al. Left ventricular hypertrophy and function in high, normal, and low-renin forms of hypertension.Hypertension 1982;4:524.

    Google Scholar 

  15. Drayer JIM, Weber MA, De Young JL. Blood pressure as a determinant of cardiac left ventricular muscle mass.Arch Intern Med 1983;143:90.

    Google Scholar 

  16. Shkhvatsabaya IK, Usubaliyev NN, Yurenev AP, et al. The interrelations of cardiac and vascular wall hypertrophy in arterial hypertension.Cardiovasc Rev Rep 1981;2:1145.

    Google Scholar 

  17. Gerstenblith G, Fleg JL, Becker LC, et al. Maximum left ventricular filling rate in healthy individuals measured by gated pool blood scans: Effect of age.Circulation 1983;68:III.

    Google Scholar 

  18. Savage DD, Drayer JIM, Henry WL, et al. Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects.Circulation 1979;59:623.

    Google Scholar 

  19. Wolinsky H. Long-term effects of hypertension on the rat aortic wall and their relation to concurrent aging changes: Morphological and chemical studies.Circ Res 1972;30:301.

    Google Scholar 

  20. Gerstenblith G, Lakatta EG, Weisfeldt ML. Age changes in myocardial function and exercise response.Prog Cardiovasc Res 1976;19:1.

    Google Scholar 

  21. Bader H. Dependence of wall stress in the human thoracic aorta on age and pressure.Circ Res 1967;30:354.

    Google Scholar 

  22. Learoyd BM, Taylor MG. Alterations with age in the viscoelastic properties of human arterial walls.Circ Res 1966;18:278.

    Google Scholar 

  23. Yin FCCP, Spurgeon HA, Kallman VC. Age-associated alterations in viscoelastic properties of canine aortic strips.Circ Res 1983;53:464.

    Google Scholar 

  24. Landowne M. The relation between intra-arterial pressure and impact pulse wave velocity with regard to age and arteriosclerosis.J Gerontol 1958;13:153.

    Google Scholar 

  25. Avolio AP, Fa-Quan D, We-Qiang L, et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: Comparison between urban and rural communities in China.Circulation 1985;71:202.

    Google Scholar 

  26. O'Rourke MF.Arterial Function in Health and Disease. New York: Churchill Livingstone, 1982:275.

    Google Scholar 

  27. Gribbin B, Pickering TG, Sleight P, et al. Effect of age and high blood pressure on baroreflex sensitivity in man.Circ Res 1971;29:424.

    Google Scholar 

  28. Bartel O, Buhler FR, Klowski W, et al. Decreased beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension.Hypertension 1980;2:130.

    Google Scholar 

  29. Featherstone JA, Veith RC, Hulter JB. Effect of age and alpha2-adrenergic stimulation on plasma norepinephrine kinetics in man.Clin Res 1984;32:69.

    Google Scholar 

  30. Kuramoto K, Matsushita S, Mifune J, et al. Electrocardiographic and hemodynamic evaluation of isoproterenol test in elderly ischemic heart disease.Jpn Circ J 1978;42:955.

    Google Scholar 

  31. Lakatta EG. Age-related alterations in the cardiovascular response to adrenergic-mediated stress.Fed Proc 1980;39:3173.

    Google Scholar 

  32. London DM, Safer ME, Weiss YA, et al. Isoproterenol sensitivity and total body clearance of propranolol in hypertensive patients.J Clin Pharmacol 1976;16:174.

    Google Scholar 

  33. Yin FCP, Spurgeon HA, Greene HL, et al. Age-associated decrease in heart rate response to isoproterenol in dogs.Mech Aging Dev 1979;10:15.

    Google Scholar 

  34. Yin FCP, Spurgeon JA, Raizes GS, et al. Age-associated decrease in chronotropic response to isoproterenol.Circulation 1976;54:II.

    Google Scholar 

  35. Ibsen II, Julius S. Pharmacologic tools for assessment of adrenergic nerve activity in human hypertension.Fed Proc 1984;43:67.

    Google Scholar 

  36. Messerli FH, Sundgaard-Rruse K, Ventura HO, et al. Essential hypertension in the elderly: Hemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels.Lancet 1983;2:983.

    Google Scholar 

  37. Hollenberg NK, Adams DF, Solomon HS, et al. Senescence and the renal vasculature in normal man.Circ Res 1974;34:309.

    Google Scholar 

  38. Shock NW. The role of the kidney in electrolyte and water regulation in the aged. In: Wolstenholme GFW, O'Connors M, eds.Ciba Foundation Colloquia on Aging: Water and Electrolyte Metabolism in Relation to Age and Sex London: J&A Churchill 1958;4:229.

    Google Scholar 

  39. Lindeman RD, Goldman R. Anatomic and physiologic age changes in the kidney.Exp Gerontol 1986;21:379.

    Google Scholar 

  40. Danziger RS, Tobin JD, Becker LC, et al. The age-associated decline in glomerular filtration in healthy normotensive volunteers: Lack of relationship to cardiovascular performance.J Am Geriatr Soc 1990;38:1127.

    Google Scholar 

  41. Lakatta EG. Hemodynamic adaptation to stress with advancing age.Acta Med Scand 1986;711(Suppl):39.

    Google Scholar 

  42. Branfonbrener M, Landowne M, Shock NW. Changes in cardiac output with age.Circulation 1955;12:447.

    Google Scholar 

  43. Oliver WJ, Cohen EI, Noel JV. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a “no salt” culture.Circulation 1975;52:146.

    Google Scholar 

  44. Crane MG, Harris JJ. Effect of aging on renin activity and aldosterone excretion.J Lab Clin Med 1976;87:947–959.

    Google Scholar 

  45. Buhler FR, Burkart F, et al. Antihypertensive beta-blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension.Am J Cardiol 1975;36:653.

    Google Scholar 

  46. Khaw KT, Barrett-Connor E. The association between blood pressure, age, and dietary sodium and potassium: A population study.Circulation 1988;77:53.

    Google Scholar 

  47. Grobbee DE, Hofman A. Does sodium restriction lower blood pressure?Br Med J 1986;293:27.

    Google Scholar 

  48. Hickler RB. Aging and hypertension; hemodynamic implications of systolic pressure trends.J Am Geriatr Soc 1983;31:421.

    Google Scholar 

  49. Nichols WW, O'Rourke MF, Avolio AP, et al. Effects of age on ventricular couplingAm J Cardiol 1985;55:1179.

    Google Scholar 

  50. Fleg JL, Tzankoff SP, Lakatta EG. Age-related augmentatin of plasma catecholamines during dynamic exercise in healthy males.J Appl Physiol 1985;59:1033.

    Google Scholar 

  51. Pfeifer MA, Weinberg CR, Cook D, et al. Differential changes in autonomic nervous system function with age and man.Am J Med 1983;75:249.

    Google Scholar 

  52. Rowe JW, Troen BR. Sympathetic nervous system and aging in man.Endocr Rev 1980;1:167.

    Google Scholar 

  53. Sowers JR. Hypertension in the elderly.Am J Med 1987;82(Suppl 1B):1.

    Google Scholar 

  54. Lakatta EG. Altered autonomic modulation of cardiovascular function with adult aging: Perspectives from studies ranging from man to cell. In: Stone HL, Weglicki WB, eds.Pathobiology of Cardiovascular Injury. Boston: Martinus Nijhoff, 1985:441.

    Google Scholar 

  55. Lakatta EG. Catecholamines and cardiovascular function in aging. In: Sacktor B, ed.Endocrinology and Aging: Endocrinology and Metabolism Clinics, Vol. 16. Philadelphia: WB Saunders, 1987:877.

    Google Scholar 

  56. Rodeheffer RJ, Gerstenblith G, Becker LC, et al. Exercise cardiac output is maintained with advancing age in healthy human subjects: Cardiac dilatation and increased stroke volume compensate for diminished heart rate.Circulation 1984;69:203–213.

    Google Scholar 

  57. Duckles SP, Carter BJ, Williams CL. Vascular adrenergic neuroeffector function does not decline in aged rats.Circ Res 1985;56:109.

    Google Scholar 

  58. Pan HY-M, Hoffman BB, Pershi RA, et al. Decline in beta-adrenergic receptor-mediated vascular relaxation with aging in man.J Pharmacol Exp Ther 1986;228:802.

    Google Scholar 

  59. Lakatta EG. Geriatric hypertension: Aggressive therapy and its physiologic rationale.Geriatrics 1986;41:44.

    Google Scholar 

  60. Lakatta EG, Yin FCP. Myocardial aging: Functional alterations and related cellular mechanisms.Am J Physiol 1982;242:11:H927.

    Google Scholar 

  61. Lakatta EG. Cardiac muscle changes in senescence.Ann Rev Physiol 1987;49:519.

    Google Scholar 

  62. Lakatta EG. Do hypertension and aging have a similar effect on the myocardium?Circulation 1977;75(Suppl I):I-69.

    Google Scholar 

  63. The European Working Party on High Blood Pressure in the Elderly. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial.Lancet 1985;1:1349–1354.

    Google Scholar 

  64. Dahlof B, Lindholm LH, Harsson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension).Lancet 1991;338:1281–1285.

    Google Scholar 

  65. National Heart Foundation of Australia. Treatment of mild hypertension in the elderly: Report by the Management Committee.Med J Austral 1981;2:398–402.

    Google Scholar 

  66. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program Cooperative Group II. Mortality by race, sex and age.JAMA 1979;242:2572–2577.

    Google Scholar 

  67. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults' principal results.Br Med J 1991;338:405–412.

    Google Scholar 

  68. Kannel WB, Wolf PA, McGee DL, et al. The Framingham study: Systolic blood pressure, arterial rigidity, and risk of stroke.JAMA 1981;245:1225–1229.

    Google Scholar 

  69. Hulley SB, Furberg CD, Gurland B, et al. Systolic Hypertension in the Elderly Program (SHEP): Antihypertensive efficacy of chlorthalidone.Am J Cardiol 1985;56:913–920.

    Google Scholar 

  70. The Systolic Hypertension in the Elderly Program (SHEP). Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension.JAMA 1991;265:3255–3264.

    Google Scholar 

  71. The Fifth Report of the Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure (JNCI).Arch Intern Med 1993;153:154–183.

    Google Scholar 

  72. The Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure. The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.Arch Intern Med 1988;148:1023–1038.

    Google Scholar 

  73. Frohlich ED. Initial Treatment of Hypertension.Hypertens Update 1991;4:1–12.

    Google Scholar 

  74. Grobbee DE, Hofman A. Does sodium restriction lower blood pressure?Br Med J Clin Res 1986;293:27–29.

    Google Scholar 

  75. Khaw KT, Barrett-Connor E. The association between blood pressure, age, and dietary sodium and potassium: A population study.Circulation 1988;77:53–61.

    Google Scholar 

  76. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure. Age and pressure change over time.Hypertension 1991;18:67–71.

    Google Scholar 

  77. Hagberg JM, Montain ST, Martin WH, Ehsani AA. Effect of exercise training in 60- to 69-year old persons with essential hypertension.Am J Cardiol 1989;64:348–353.

    Google Scholar 

  78. Jajich CL, Ostfeld AM, Freeman DH, Jr. Smoking and coronary heart disease mortality in the elderly.JAMA 1984;252:2831–2834.

    Google Scholar 

  79. LaCroix AZ, Lang J, Scherr P, et al. Smoking and mortality among older men and women in three communities.N Engl J Med 1991;324:1619–1625.

    Google Scholar 

  80. Christlieb AR. Treatment selection considerations for the hypertensive diabetic patient.Arch Intern Med 1990;160:1167–1174.

    Google Scholar 

  81. Elveback L, Lie JT. Continued high prevalence of coronary artery disease at autopsy in Holmstead County, Minnesota, 1950–1970.Circulation 1984;70:345–349.

    Google Scholar 

  82. Benfante R, Reed D. Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA 1990;263:393–396.

    Google Scholar 

  83. Sorkin JD, Andres R, Muller DC, et al. Cholesterol as a risk factor for coronary heart disease in elderly men. The Baltimore Longitudinal Study on Aging.Ann Epidemiol 1992;2:59–67.

    Google Scholar 

  84. Aronow WS, Koenigsberg M, Schwartz KS. Usefulness of echocardiographic left ventricular hypertrophy in predicting new coronary events and atherothrombotic brain infarction in patients over 62 years of age.Am J Cardiol 1988;61:1130–1132.

    Google Scholar 

  85. Levy D, Garrison RJ, Savage DD, et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study.Ann Intern Med 1989;110:101–107.

    Google Scholar 

  86. Warram JH, Laffel LMB, Valsania P, et al. Excess mortality associated with diuretic therapy in diabetes mellitus.Arch Intern Med 1991;151:1350–1356.

    Google Scholar 

  87. Samuelsson O. Hypertension in middle-aged men: Management, morbidity, and prognostic factors during long-term hypertensive care.Acta Med Scand 1985;702(Suppl):1–79.

    Google Scholar 

  88. Messerli FH. The age factor in hypertension.Hosp Pract 1986;20:103–112.

    Google Scholar 

  89. Wetzchewald D, Klaus D, Geranin G, et al. Regression of left ventricular hypertrophy by felodipine or a combination of felodipine and metoprolol.J Cardiovasc Pharmacol 1990;15(Suppl 4):S48.

    Google Scholar 

  90. Schulman SP, Weiss JL, Becker LC, et al. The effects of antihypertensive therapy on left ventricular mass in elderly patients.N Engl J Med 1990;322:1350.

    Google Scholar 

  91. Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction—results of the survival and ventricular enlargement trial.N Engl J Med 1992;327:669–677.

    Google Scholar 

  92. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.N Engl J Med 1992;327:685–691.

    Google Scholar 

  93. Omvik P, Lund-Johansen P. Comparison of the hemodynamic effects of five calcium channel blockers at rest and during exercise in essential hypertension.Ann Clin Res 1988;20:(Suppl 48):23–30.

    Google Scholar 

  94. Gradman AH. Hemodynamic effects of the vascular selective calcium antagonist felodipine in patients with impaired left ventricular function.Am Heart J 1992;19:809–815.

    Google Scholar 

  95. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction.N Engl J Med 1988;319:385–392.

    Google Scholar 

  96. Ljung B. Vascular selectivity of felodipine. Drugs 1987;29:(Suppl II):46–58.

    Google Scholar 

  97. Culling W, Ruttley MSM, Sheridan DJ. Acute hemodynamic effects of feldopine during beta-blockade in patients with coronary artery disease.Br Heart J 1984;52:431–434.

    Google Scholar 

  98. Joshi PI, Dalal JJ, Ruttley MSJ, et al. Nifedipine and left ventricular function in beta-blocked patients.Br Heart J 1981;45:457–459.

    Google Scholar 

  99. Dunselman PHJ, Kuntz CEE, van Bruggen A, et al. Efficacy of felodipine in congestive heart failure.Eur Heart J 1989;10:354–364.

    Google Scholar 

  100. Kassis E, Amtorp O, Waldorff S, Frit-Hansen PF. Efficacy of felodipine in chronic congestive heart failure: A placebo controlled haemodynamic study at rest and during exercise and orthostatic stress.Br Heart J 1987;58:505–511.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, 4940 Eastern Avenue, 21224, Baltimore, MD

    Edward G. Lakatta MD & Jerome L. Fleg

  2. Preventive Cardiology Programs, St. Louis University, St. Louis, MO

    Jerome D. Cohen

  3. Alton Ochsner Medical Foundation, New Orleans, LA

    Edward D. Frohlich

  4. Division of Cardiovascular Disease, The Western Pennsylvania Hospital, Pittsburgh, PA

    Alan H. Gradman

Authors
  1. Edward G. Lakatta MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jerome D. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jerome L. Fleg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Edward D. Frohlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alan H. Gradman
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Proceedings of a symposium held in Atlanta, Georgia on March 2, 1991.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lakatta, E.G., Cohen, J.D., Fleg, J.L. et al. Hypertension in the elderly: Age- and disease-related complications and therapeutic implications. Cardiovasc Drug Ther 7, 643–653 (1993). https://doi.org/10.1007/BF00877817

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00877817

Key Words

Search

Navigation